T
Tapdi Oksijen Ozel Saglik ve Egitim Hizmetleri Sanayi Ticaret AS
IST:TNZTP.E
Tapdi Oksijen Ozel Saglik ve Egitim Hizmetleri Sanayi Ticaret AS
IST:TNZTP.E
Price:
22.22
TRY
-1.68%
Market Closed
Market Cap:
₺8.9B
Relative Value
The Relative Value of one TNZTP.E stock under the Base Case scenario is 21.78 TRY. Compared to the current market price of 22.22 TRY, Tapdi Oksijen Ozel Saglik ve Egitim Hizmetleri Sanayi Ticaret AS is Overvalued by 2%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TNZTP.E
Relative Value
Base Case
21.78
TRY
Overvaluation 2%
T
Multiples Across Competitors
TNZTP.E Competitors Multiples
Tapdi Oksijen Ozel Saglik ve Egitim Hizmetleri Sanayi Ticaret AS Competitors
Tapdi Oksijen Ozel Saglik ve Egitim Hizmetleri Sanayi Ticaret AS Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| TR |
T
|
Tapdi Oksijen Ozel Saglik ve Egitim Hizmetleri Sanayi Ticaret AS
IST:TNZTP.E
|
8.9B TRY | 3.4 | 21.2 | 11.6 | 15.6 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
112.7B USD | 1.5 | 16.6 | 9.7 | 12.6 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 7.1 | 40.8 | 31.9 | 40 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
22.1B ZAR | 0.8 | 13.1 | 8.9 | 8.9 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
79.8B MYR | 3.1 | 38 | 15.6 | 23.3 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
17.4B USD | 0.8 | 12.4 | 5.9 | 7.3 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
16B ZAR | 0.6 | 4.1 | 16.4 | -47.5 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
81.6B BRL | 1.5 | 17.4 | 7.5 | 8.8 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
93.4B CNY | 4.2 | 29 | 20.8 | 20.8 | |
| US |
|
Ensign Group Inc
NASDAQ:ENSG
|
11.6B USD | 2.3 | 33.4 | 20.9 | 26 | |
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 4.4 | 58.5 | 28.4 | 41.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
